News and Press Releases

Lytix Biopharma Publishes Comprehensive Review on the Transformative Potential of Oncolytic Peptides in Leading Cancer Journal (JITC)

17 February 2026 -- Oslo, Norway -- Lytix Biopharma AS, a clinical-stage immuno-oncology company, today announced the publication of a review article in the Journal of ImmunoTherapy of Cancer (JITC)....

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026

Sandakerveien 138, 0484 Oslo, Norway

STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi

European Commission grants approval for Gotenfia, a golimumab biosimilar to Simponi that was developed by Bio-Thera and will be marketed by STADA Launch preparations are underway to bring the second...

Category: BioManufacturing, Drug Discovery, Manufacturing and Packing, Other, Pharmaceutical
Posted: February 13, 2026

Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant

11 February 2026 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 11, 2026

168 Third Avenue Waltham, MA 02451

Neogap secures SEK 87 million to advance clinical development of its personalised immunotherapy

11 February 2026 -- Solna, Sweden -- Neogap Therapeutics AB, a Swedish biotechnology company developing personalised immunotherapy for cancer treatment, has raised SEK 87 million in a financing round led...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 11, 2026

Stiftelsen Cancercentrum Karolinska (CCK) Visionsgatan 56 171 64 Solna, Sweden

Syngene Collaborates with Johns Hopkins University to Advance Early-Stage Drug Discovery

India/UK/US, 11 February, 2026: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early‑stage drug...

Category:
Posted: February 11, 2026

Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bangalore, Karnataka – 560 099

Cold Chain Technologies boosts its commitment to Cell & Gene Therapies by partnering with Gobi Technologies

Cold Chain Technologies (CCT) has announced a strategic partnership with Gobi Technologies to give customers access to a greater range of temperature-controlled containers for Cell and Gene Therapies. The deal...

Category:
Posted: February 11, 2026

29 Everett Street, Holliston, MA 01746

Moderna Receives MHRA Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

The LP.8.1 vaccine is the first commercially licenced mRNA vaccine to be manufactured in the UK at the Moderna Innovation and Technology Centre in Oxfordshire The updated vaccines will be...

Category: Biotechnology, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

Global Headquarters 200 Technology Square Cambridge, MA 02139

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

Financing led by Investissement Québec with continued support from long-standing investors Plans include the acceleration of clinical development of breakthrough GPCR targeting treatments for patients. 10 February 2026 -- Montreal,...

Category: Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

7171 Frederick Banting Montreal, QC H4S 1Z9 Canada

SPT Labtech and BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research

Automated workflow to be highlighted at SLAS 2026, 7-11 February, Boston Collaboration combines precision liquid handling technology with Transcreener ADP2 fluorescence polarization assay for screening of VPS4B ATPase inhibitors. 9...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 9, 2026

SPT Labtech Ltd. Melbourn Science Park Melbourn Hertfordshire SG8 6HB United Kingdom

ACG Packaging Materials Joins World Economic Forum’s Global Lighthouse Network as World’s First Pharmaceutical Packaging Company

ACG Packaging Materials today announced that its Shirwal facility has been named a global Lighthouse and welcomed into the World Economic Forum’s (WEF) Lighthouse Network (GLN). This marks ACG’s second...

Category:
Posted: February 5, 2026

D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN

ALTx Therapeutics launches into the Slingshot accelerator with £12.55 million of funding

Based on the pioneering work of British scientist Simon Boulton, ALTx leverages fundamental insights in cancer cell immortalisation to develop novel treatments for cancer Spinning out of The Francis Crick...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 5, 2026

Santec Announces the Opening of European Service Centre

4 February 2026 -- Komaki, Japan -- santec Holdings Corporation is pleased to announce the establishment of a new European service centre. The newly established subsidiary, Santec Europe Czech s.r.o....

Category: Drug Discovery, Other
Posted: February 4, 2026

5823, Ohkusa Nenjozaka, Komaki, Aichi, Japan 485-0802

Levicept Announces the Appointment of James Sandy as Chief Development Officer

Leadership Team Strengthened to Support Clinical Development of LEVI-04 for Osteoarthritis 4 February 2026 -- Sandwich, UK -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: February 4, 2026

Innovation House Discovery Park Ramsgate Road Sandwich Kent CT13 9ND

Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia

Publication presents clinical findings highlighting evenamide’s glutamatergic modulation as a therapeutic strategy for patients with inadequate response or treatment-resistant schizophrenia (TRS) By targeting the hippocampus region of the brain, evenamide...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 3, 2026

via Antonio Meucci 3 20091 Bresso (Mi) Italy

Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation

ACES-EMB is the first randomized-controlled trial to compare dd-cfDNA surveillance to routine biopsy in organ transplantation, highlighting the benefits of Prospera in organ rejection 28 January 2026 -- Texas, US...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2026

13011 McCallen Pass Building A Suite 100 Austin, TX 78753